These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 18760600)
21. Potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives. Patel AB; Malpass JR J Med Chem; 2008 Nov; 51(21):7005-9. PubMed ID: 18841955 [TBL] [Abstract][Full Text] [Related]
22. Pyrazole derivatives as partial agonists for the nicotinic acid receptor. van Herk T; Brussee J; van den Nieuwendijk AM; van der Klein PA; IJzerman AP; Stannek C; Burmeister A; Lorenzen A J Med Chem; 2003 Aug; 46(18):3945-51. PubMed ID: 12930155 [TBL] [Abstract][Full Text] [Related]
23. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A. Ding FX; Shen HC; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Wang J; Tong X; Holt TG; Chen Q; Waters MG; Hammond ML; Tata JR; Colletti SL Bioorg Med Chem Lett; 2010 Jun; 20(11):3372-5. PubMed ID: 20452209 [TBL] [Abstract][Full Text] [Related]
24. Agonist lead identification for the high affinity niacin receptor GPR109a. Gharbaoui T; Skinner PJ; Shin YJ; Averbuj C; Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Cherrier MC; Webb PJ; Tamura SY; Zou N; Rodriguez N; Boatman PD; Sage CR; Lindstrom A; Xu J; Schrader TO; Smith BM; Chen R; Richman JG; Connolly DT; Colletti SL; Tata JR; Semple G Bioorg Med Chem Lett; 2007 Sep; 17(17):4914-9. PubMed ID: 17588745 [TBL] [Abstract][Full Text] [Related]
25. A novel treatment target for Parkinson's disease. Wakade C; Chong R J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298 [TBL] [Abstract][Full Text] [Related]
26. Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia. Schmidt D; Smenton A; Raghavan S; Carballo-Jane E; Lubell S; Ciecko T; Holt TG; Wolff M; Taggart A; Wilsie L; Krsmanovic M; Ren N; Blom D; Cheng K; McCann PE; Gerard Waters M; Tata J; Colletti S Bioorg Med Chem Lett; 2009 Aug; 19(16):4768-72. PubMed ID: 19592242 [TBL] [Abstract][Full Text] [Related]
27. Discovery of a novel class of PPARdelta partial agonists. Shearer BG; Patel HS; Billin AN; Way JM; Winegar DA; Lambert MH; Xu RX; Leesnitzer LM; Merrihew RV; Huet S; Willson TM Bioorg Med Chem Lett; 2008 Sep; 18(18):5018-22. PubMed ID: 18722772 [TBL] [Abstract][Full Text] [Related]
28. Discovery of novel pyrrole derivatives as potent agonists for the niacin receptor GPR109A. Miyazawa Y; Yamaguchi T; Yamaguchi M; Tago K; Tamura A; Sugiyama D; Aburatani T; Nishizawa T; Kurikawa N; Kono K Bioorg Med Chem Lett; 2020 May; 30(10):127105. PubMed ID: 32199732 [TBL] [Abstract][Full Text] [Related]
29. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies. Yuzlenko O; Kieć-Kononowicz K J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794 [TBL] [Abstract][Full Text] [Related]
30. Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403. Shen HC Expert Opin Ther Pat; 2009 Aug; 19(8):1149-55. PubMed ID: 19566484 [TBL] [Abstract][Full Text] [Related]
31. Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies. Grazioso G; Pomè DY; Matera C; Frigerio F; Pucci L; Gotti C; Dallanoce C; De Amici M Bioorg Med Chem Lett; 2009 Nov; 19(22):6353-7. PubMed ID: 19804970 [TBL] [Abstract][Full Text] [Related]